Entero Healthcare Solutions Ltd (ENTERO) Q3FY26 Concall Summary - Dec-2025 Qtr
Performance Overview
- The company demonstrated strong performance, achieving a revenue of 1,707 crores, marking a 26% year-on-year growth and a 9% quarter-on-quarter increase. On a like-to-like basis, adjusted for net margin sales recognition and a subsidiary divestment, revenue growth was 28.5% year-on-year.
- Organic growth was a key highlight, reaching 17.1% year-on-year, the highest for the financial year, significantly outpacing the industry's 12% growth and thereby increasing market share.
- Profitability saw significant improvement, with EBITDA growing 36% year-on-year to 68 crores and the EBITDA margin expanding by 30 basis points to 4.0%. This was driven by better business mix, margin-accretive categories, and procurement efficiencies.
- The company made substantial progress in working capital management, with net working capital days improving to 61 days on a like-to-like basis, leading to a strong positive operating cash flow of 49 crores for the quarter.
- Strategic expansion in the Med Tech segment was a major focus, with the closure of key acquisitions expected to push the segment's annualized revenue over 1,000 crores and provide a significant boost to overall company margins.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.